TELA Bio, Inc. (TELA) vs Xtant Medical Holdings, Inc. (XTNT)

TELA Bio, Inc. and Xtant Medical Holdings, Inc. are both Medical Devices companies. TELA Bio, Inc. and Xtant Medical Holdings, Inc. are of similar size ($57.3M and $52.9M). TELA Bio, Inc. grew revenue faster over the last twelve months: 6.09% against −14.3%. Xtant Medical Holdings, Inc. has the higher net margin (−10.2% vs −51.5%) and the higher return on invested capital (−12.4% vs −217.1%). Across the 17 metrics below, Xtant Medical Holdings, Inc. leads on 10 and TELA Bio, Inc. on 7.

Valuation

Metric TELA XTNT Medical Devices median
P/E n/m n/m 22.18
P/S 0.91 0.49 2.70
P/B n/m 1.33 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 1.27 0.60 2.38
Earnings yield (61.11%) (20.95%) (8.22%)
Free cash flow yield (47.86%) (0.86%) (7.80%)

Profitability

Metric TELA XTNT Medical Devices median
Gross margin 68.29% 59.39% 56.01%
Operating margin (42.56%) (9.58%) (15.03%)
Net margin (51.53%) (10.17%) (20.40%)
Free cash flow margin (39.57%) (0.42%) (7.24%)
Return on equity 1,232.54% (25.16%) (15.32%)
Return on assets (64.71%) (12.16%) (19.72%)
Return on invested capital (217.11%) (12.43%) (10.33%)

Growth

Metric TELA XTNT Medical Devices median
Revenue growth (TTM) 6.09% (14.28%) 8.80%
EPS growth (last fiscal year) 37.59% 125.00% —
Revenue growth, 5-year CAGR 34.54% 20.22% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TELA XTNT Medical Devices median
Debt to equity (3.53) 0.57 0.07
Current ratio 2.99 2.16 2.50
Net debt to EBITDA (0.15) 0.65 0.49

Dividend

Metric TELA XTNT Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric TELA XTNT Medical Devices median
Market cap 57.33m 52.87m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack